Articles and Information
Form 7 Monthly Progress Report June 2026
Form 7 Monthly Progress Report April 2025 Name of Listed Issuer: Trading Symbol: Number of
July 12, 2026
- Articles and Information
Dr James Bond on Biomark
BioMark Diagnostics Inc.
BioMark Diagnostics is leading the world in early-stage cancer detection with an oncology focus designed to improve patient outcomes.
Categories
Archives
Sign up for the latest Biomark news
No paperwork, no hassle. We keep things digital, easy and regular.
*Zero Spam Policy. You will need to confirm your email address to receive our news to your inbox.
Related articles ...
Articles and Information
Form 7 Monthly Progress Report May 2026
Form 7 Monthly Progress Report April 2025 Name of Listed Issuer: Trading Symbol: Number of
July 12, 2026
News
BioMark Diagnostics Secures Landmark Canadian and European Patent Allowances for Early-Stage Lung Cancer Blood Test
BioMark Diagnostics Secures Landmark Canadian and European Patent Allowances for Early-Stage Lung Cancer Blood Test
July 12, 2026
News
BioMark Secures Broad U.S. Patent for Urine-Based Lung Cancer Screening, Expanding Differentiated Liquid Biopsy Testing Platform
BioMark Secures Broad U.S. Patent for Urine-Based Lung Cancer Screening, Expanding Differentiated Liquid Biopsy Testing
June 11, 2026
Articles and Information
Form 7 Monthly Progress Report April 2026
Form 7 Monthly Progress Report April 2025 Name of Listed Issuer: Trading Symbol: Number of
May 5, 2026
1 604 370 0779
130 3851 Shell Road
Richmond BC
Canada V6X 2W2